Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001640334-20-000651
Filing Date
2020-03-30
Accepted
2020-03-30 12:33:54
Documents
44
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K devv_10k.htm 10-K 343846
2 CERTIFICATION devv_ex311.htm EX-31.1 8209
3 CERTIFICATION devv_ex321.htm EX-32.1 3386
  Complete submission text file 0001640334-20-000651.txt   1671116

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT jdct-20191231.xml EX-101.INS 193966
5 XBRL TAXONOMY EXTENSION SCHEMA jdct-20191231.xsd EX-101.SCH 18531
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE jdct-20191231_lab.xml EX-101.LAB 152964
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE jdct-20191231_cal.xml EX-101.CAL 11906
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jdct-20191231_pre.xml EX-101.PRE 137064
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE jdct-20191231_def.xml EX-101.DEF 39013
Mailing Address 500 NORTH MICHIGAN AVENUE #600 CHICAGO IL 89015
Business Address 500 NORTH MICHIGAN AVENUE #600 CHICAGO IL 89015 (773) 236-8132
BIOSCIENCE NEUTRACEUTICALS, INC. (Filer) CIK: 0001555995 (see all company filings)

EIN.: 460745348 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36604 | Film No.: 20755434
SIC: 5900 Retail-Miscellaneous Retail